home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,151 rows where filing_year = 2019 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • third_quarter 302
  • fourth_quarter 289
  • second_quarter 287
  • first_quarter 273

issue_code 1

  • MED · 1,151 ✖

filing_year 1

  • 2019 · 1,151 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2260501 LIBERTY GOVERNMENT AFFAIRS 8efe606c-3b0f-4b86-8cb6-322468880539 1T LIBERTY GOVERNMENT AFFAIRS 401104531 WEEDMAPS 2019 first_quarter MED Medical marijuana research. HOUSE OF REPRESENTATIVES,SENATE 5000   0 1 2019-02-01T11:14:41.910000-05:00
2260526 BROWN RUDNICK LLP cd42d749-9ef3-41f7-97f9-3bcb1763e948 1T BROWN RUDNICK LLP 287895 HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS) 2019 first_quarter MED The Verifying Accurate Leading-edge IVCT Development Act. HOUSE OF REPRESENTATIVES,SENATE 5000   0 1 2019-02-08T15:40:19.023000-05:00
2260639 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5797c503-46cb-4ec1-83c1-311af7a761b9 1T CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 23ANDME, INC. 2019 first_quarter MED Data Privacy, consumer genomics HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2019-03-08T14:44:42.757000-05:00
2260828 REPUBLIC CONSULTING, LLC aeb33366-a4de-4c70-9877-d780ea2a8637 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2019 first_quarter MED Monitor Data and Science policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-03-30T12:58:06.777000-04:00
2260859 AUBURN HEALTH STRATEGIES, LLC 01e79168-b068-402c-af6f-bdd84a7fe92b Q1 AUBURN HEALTH STRATEGIES, LLC 292697 NEUROTECH, LLC 2019 first_quarter MED EEG monitoring HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-03-30T22:41:37.510000-04:00
2260903 FRANCIS EDWARD & CRONIN, INC. 55b6e8d8-571b-48de-90a5-3e2a5a68fd49 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2019 first_quarter MED Issues and legislation related to Alzheimer's disease research Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2019-04-01T08:31:40.857000-04:00
2260905 FRANCIS EDWARD & CRONIN, INC. f582ce28-d171-4fdd-b31a-68d91d779105 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2019 first_quarter MED Issues and legislation related to diabetes treatment and diagnosis Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2019-04-01T08:34:42.423000-04:00
2260986 OTT BIELITZKI & O'NEILL PLLC d275bae6-2a46-4a48-ac05-389154d8ab3e Q1 OTT BIELITZKI & O'NEILL PLLC 401103584 BIOPORTO DIAGNOSTICS A/S 2019 first_quarter MED Educating officials about a health care diagnostic tool. Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-04-01T13:32:00.060000-04:00
2261333 MCDERMOTT WILL & SCHULTE LLP 6dc3c207-e58a-45e8-9c02-09833450a29e Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ABIOMED, INC. 2019 first_quarter MED Issues related to Medicare reimbursement and the medical device tax. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-03T09:41:09.097000-04:00
2261347 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 0bf07e14-c6d7-45df-9341-0877ec2438f3 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2019 first_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18700   0 0 2019-04-03T10:29:21.487000-04:00
2261359 WAKE FOREST UNIVERSITY HEALTH SCIENCES d8f9fe31-e563-44a5-90f6-9017870e08fc Q1 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2019 first_quarter MED VA Research funding and access; VA Missions Act implementation; FY 2020 President's Budget Request for VA Research Programs; Higher Education Act reauthorization; animal research legislation; FY 2020 President's Budget Request for Departments of Labor/HHS; Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2019-04-03T10:59:32.273000-04:00
2261408 MR. BRIAN KELLY 8058f3de-b187-44a2-bf72-9b4241adf05c Q1 MR. BRIAN KELLY 40024191 INTELLIA THERAPEUTICS 2019 first_quarter MED WHO Gene Editing Summit Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office 15000   0 0 2019-04-03T12:18:50.910000-04:00
2261631 JUSTICE FOR JAKE fbdf6fbe-9936-42b4-8440-c2b3c2305fc9 Q1 JUSTICE FOR JAKE 401104713 JUSTICE FOR JAKE 2019 first_quarter MED Project Vision - Overdose death decrease Office of the Vice President of the United States,President of the U.S.,White House Office     0 0 2019-04-04T10:20:23.280000-04:00
2261760 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION ed38ec67-d7b7-4760-be8c-ebad0321dd6e Q1 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 401103437 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 2019 first_quarter MED Medicare Advantage Plans on Prior Authorization Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2019-04-04T14:11:45.137000-04:00
2261789 FAEGRE DRINKER BIDDLE & REATH LLP 8f68fab7-890e-488f-84a7-bc181f6045bc Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH 2019 first_quarter MED H.R. 6378 Pandemic All Hazards Preparedness Act Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; P.L. 115-411 Implementation of Global Health Innovation Act. HOUSE OF REPRESENTATIVES 20000   0 0 2019-04-04T14:47:03.670000-04:00
2261793 FAEGRE DRINKER BIDDLE & REATH LLP 4e42acb1-518a-4e4a-8647-95589203082b Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2019 first_quarter MED Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act.   10000   0 0 2019-04-04T14:50:06.830000-04:00
2261797 FAEGRE DRINKER BIDDLE & REATH LLP 2f124b13-134a-402f-9171-a943839c5367 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2019 first_quarter MED Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research; H.R. 6378 Pandemic and All Hazards Preparedness Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; H. Res 214 Supporting the goals to protect U.S. military personnel from malaria. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-04-04T14:51:07.567000-04:00
2261970 NEOGENOMICS LABORATORIES 40eb34b0-cfb4-4026-b997-12a9cc4c17e1 Q1 NEOGENOMICS LABORATORIES 401105014 NEOGENOMICS LABORATORIES 2019 first_quarter MED Diagnostic Accuracy and Innovation Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2019-04-05T09:01:48.090000-04:00
2262008 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 1647f2c7-f0c6-4949-ba00-2998d6e9452d Q1 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2019 first_quarter MED Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   63232 0 0 2019-04-05T10:55:09.827000-04:00
2262164 NATIONAL MULTIPLE SCLEROSIS SOCIETY b00670ee-5858-4b25-aee7-ac66f40bc007 Q1 NATIONAL MULTIPLE SCLEROSIS SOCIETY 69674 NATIONAL MULTIPLE SCLEROSIS SOCIETY 2019 first_quarter MED N/A Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   108346 0 0 2019-04-05T15:27:48.200000-04:00
2262315 NATURAL RESOURCE RESULTS LLC 70c37d0a-80fb-4417-9116-095752b76c86 Q1 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2019 first_quarter MED Support budget and approps for grants to cooperatives on medical isotope MO-99 production facility. Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 10000   0 0 2019-04-07T11:11:04.240000-04:00
2262338 MARSHALL BRACHMAN f0dbe498-338c-4ad2-aa19-a90e006e85a4 Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2019 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2019-04-07T15:21:22.620000-04:00
2262375 AUBURN HEALTH STRATEGIES, LLC 619ee755-dbca-41cd-bc71-0fc91e938c0e Q1 AUBURN HEALTH STRATEGIES, LLC 292697 API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) 2019 first_quarter MED quality of laboratory testing Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-07T20:32:45.307000-04:00
2262390 FAEGRE DRINKER BIDDLE & REATH LLP 6c4b4498-c655-42da-9b00-7be4cc9b090e Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2019 first_quarter MED Preeclampsia Research Issues. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2019-04-08T09:38:04.293000-04:00
2262443 MCDERMOTT+ LLC 27d4a464-5a94-403b-808a-528b7b229624 Q1 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2019 first_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2019-04-08T11:26:44.167000-04:00
2262626 IPOLICY SOLUTIONS 7f287f7e-5114-4835-a962-3e6185efde25 Q1 IPOLICY SOLUTIONS 401105127 23ANDME, INC. 2019 first_quarter MED No bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-08T15:15:35.550000-04:00
2262637 IPOLICY SOLUTIONS 9bc0a658-7a3f-4a25-8150-96dfdbca70a6 Q1 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2019 first_quarter MED No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-08T15:24:45.983000-04:00
2262652 IPOLICY SOLUTIONS 35518392-6ce4-4c62-a986-1ff4d3d10d5e Q1 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2019 first_quarter MED No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-08T15:35:54.170000-04:00
2262716 IPOLICY SOLUTIONS 10cf70d8-c4df-493d-875d-090790e30e1a Q1 IPOLICY SOLUTIONS 401105127 SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) 2019 first_quarter MED No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Draft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-08T18:00:16.177000-04:00
2262754 AMERICAN COLLEGE OF CLINICAL PHARMACY d34f67f2-7da7-455b-b142-9f4b17f1ca1e Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2019 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2019-04-09T09:12:15.970000-04:00
2262886 UC HEALTH 35077f33-fe7b-4a20-b0a0-080de7851d81 Q1 UC HEALTH 401103195 UC HEALTH 2019 first_quarter MED Research, NIH funding Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-09T13:02:53.750000-04:00
2263622 TCH GROUP, LLC 7604579d-522d-43fc-b67f-9a519ebb10d1 Q1 TCH GROUP, LLC 51478 INTERNATIONAL AIDS VACCINE INITIATIVE 2019 first_quarter MED FY 19 Consolidated Appropriations Act (HJ Res 31/ PL 116-6) and FY 20 State Foreign Operations Subcommittee Appropriations bills. Specifically, continued Federal funding under USAID for AIDS vaccine research and development. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-10T15:58:10.493000-04:00
2263732 BROYDRICK & ASSOCIATES d2390970-88ce-41bf-9adc-f1177679e358 Q1 BROYDRICK & ASSOCIATES 7268 EXACT SCIENCES 2019 first_quarter MED Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-10T21:34:22.110000-04:00
2263968 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 506c1453-4da6-4718-929d-e490371677d4 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2019 first_quarter MED FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor, HHS, NIH Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-04-11T11:53:02.307000-04:00
2263982 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2522e604-e3ab-4935-bcff-e87998f62051 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2019 first_quarter MED cancer research at DOD and NIH FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor-HHS-Education Appropriations Act, NIH HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2019-04-11T12:01:07.363000-04:00
2263997 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 84a0ffb0-8534-4e3a-bdf9-b641f68a4e79 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2019 first_quarter MED Research in hematology Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-04-11T12:11:13.627000-04:00
2264026 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d9c94825-b406-4525-b6e3-e47580042fa7 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2019 first_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2019-04-11T12:21:24.703000-04:00
2264092 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e1e3d1b3-3a53-484f-879e-313d04127c66 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2019 first_quarter MED Research in Endocrinology, Standardization of Hormone Testing Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-04-11T12:55:49.387000-04:00
2264227 LNE GROUP eaaa65a7-35cb-479b-9146-4662120df975 Q1 LNE GROUP 308811 HOSPICE OF THE WESTERN RESERVE 2019 first_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2019-04-11T15:15:53.050000-04:00
2264241 LNE GROUP 6dc00d59-152e-4774-93e5-70554614f036 Q1 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2019 first_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-11T15:27:58.580000-04:00
2264251 INTUITIVE SURGICAL, INC. 51814481-ff6b-4299-85bb-93ca94b06762 Q1 INTUITIVE SURGICAL, INC. 400670004 INTUITIVE SURGICAL, INC. 2019 first_quarter MED comparative effectiveness research in healthcare Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2019-04-11T15:33:01.307000-04:00
2264274 LNE GROUP edd0e94d-e3c5-45ce-a085-1da5a21a580e Q1 LNE GROUP 308811 PARKER HANNIFIN 2019 first_quarter MED lobbied on medical issues HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) 80000   0 0 2019-04-11T15:39:05.987000-04:00
2264385 ATLAS ADVOCACY b6b03d04-816d-4a24-a157-632f2dc6ccb7 Q1 ATLAS ADVOCACY 401100069 BLADDER CANCER ADVOCACY NETWORK 2019 first_quarter MED CDMRP; Disease Awreness resolution HOUSE OF REPRESENTATIVES,SENATE 8500   0 0 2019-04-11T17:27:57.967000-04:00
2264489 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa100c1f-7338-4eeb-b3b3-2c2e3a65f4aa 1A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2019 first_quarter MED FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor, HHS, NIH HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-12T08:58:55.207000-04:00
2264507 UPSTREAM CONSULTING, INC. fcbdbcf5-c6db-4558-9917-bf786532c336 Q1 UPSTREAM CONSULTING, INC. 88278 RARE ACCESS ACTION PROJECT 2019 first_quarter MED Coverage for rare disease therapies. HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-12T09:44:05.627000-04:00
2264512 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER ed4c2a27-d660-4889-94da-cc9bed4acc76 Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2019 first_quarter MED NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, ACE Act for kids Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   40568 0 0 2019-04-12T10:03:07.977000-04:00
2264565 FAMILIES USA FOUNDATION, INC. 76b93e3f-8c0f-4e58-b938-9688d97b6693 Q1 FAMILIES USA FOUNDATION, INC. 14108 FAMILIES USA FOUNDATION INC 2019 first_quarter MED S.184Gun Violence Prevention Research Act - authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2019-04-12T10:55:30.653000-04:00
2264876 60 PLUS ASSOCIATION 9e596569-74d8-4933-9fea-a300b671bb52 Q1 60 PLUS ASSOCIATION 41988 60 PLUS ASSOCIATION 2019 first_quarter MED Support the Right to Try Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office     0 0 2019-04-12T14:45:35.763000-04:00
2264943 THE CJR GROUP, INC. 74eda7be-9168-49ca-9c82-02589bc31181 Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2019 first_quarter MED NIH funding, mental health initiatives HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-12T15:29:58.990000-04:00
2264957 MUNK POLICY & LAW 4efc937f-ef78-4cdf-ba41-efc7ed8241e5 Q1 MUNK POLICY & LAW 401105075 SOUTHERN METHODIST UNIVERSITY 2019 first_quarter MED Traumatic Brain injury Research HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-12T15:39:05.173000-04:00
2265166 MOLNLYCKE HEALTH CARE US, LLC 2479c5b1-cb87-4aab-9235-644d2c5c2f5c Q1 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2019 first_quarter MED Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2019-04-14T12:52:41.547000-04:00
2265197 COMMONWEALTH POLICY SOLUTIONS fe078d36-aaed-4a1c-81be-15edd16b7503 Q1 COMMONWEALTH POLICY SOLUTIONS 401105004 TRISALUS LIFE SCIENCES 2019 first_quarter MED Medical device development for oncology, drug delivery for oncology HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-14T13:18:49.537000-04:00
2265198 COMMONWEALTH POLICY SOLUTIONS 7285dfe7-440f-4921-ab01-20f2a99e3bdc Q1 COMMONWEALTH POLICY SOLUTIONS 401105004 RARE ACCESS ACTION PROJECT 2019 first_quarter MED Reimbursement for rare disease patient care HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-14T13:20:50.227000-04:00
2265828 THE CONSILIO GROUP 8aa87597-39d5-483f-9bc5-921c1f27b7b6 Q1 THE CONSILIO GROUP 400374717 MADEN TECH CONSULTING, INC. 2019 first_quarter MED Infrastructure rebuilding. Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2019-04-15T13:51:11.077000-04:00
2265942 FEDERAL SOLUTIONS, LLC 5568accc-1545-465d-ae36-ba96331df988 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2019 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2019-04-15T14:35:51.647000-04:00
2266482 THE PETRIZZO GROUP, INC. d918af09-ad5f-4e97-8b33-223b3c70be8f Q1 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2019 first_quarter MED Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2019-04-15T23:31:22.277000-04:00
2266490 THE PETRIZZO GROUP, INC. f3aabc08-b910-4c26-b0da-03d3f575dbb4 Q1 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2019 first_quarter MED Advocated for Medicare Part B packaged payment reforms. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Vice President of the U.S.,White House Office 100000   0 0 2019-04-15T23:41:24.630000-04:00
2266504 THE PETRIZZO GROUP, INC. ecb60f5a-c3ee-4b79-b3c4-245e401b943d Q1 THE PETRIZZO GROUP, INC. 305932 UNITED BIOMEDICAL, INC. 2019 first_quarter MED Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE,White House Office 50000   0 0 2019-04-15T23:53:28.657000-04:00
2266848 SQUIRE PATTON BOGGS 581baea6-3726-4e73-9319-5c742674d52f Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2019 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2019-04-16T11:13:32.880000-04:00
2266896 O'NEILL AND ASSOCIATES 73f8789c-015c-41ba-a84f-831d3c07c376 Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2019 first_quarter MED Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-04-16T11:19:53.293000-04:00
2266970 SQUIRE PATTON BOGGS 4370ef50-fc7b-4ca0-8d9a-bea51c6654b8 Q1 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2019 first_quarter MED National Library of Medicine publication and archive matters. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2019-04-16T11:44:34.283000-04:00
2267005 SQUIRE PATTON BOGGS fcd0783e-ee83-4265-8203-1a67f2df1e84 Q1 SQUIRE PATTON BOGGS 30906 MOLNLYCKE HEALTH CARE US, LLC 2019 first_quarter MED Working with government officials to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-04-16T11:54:58.853000-04:00
2267330 WINNING STRATEGIES WASHINGTON b1bb7f36-1a4e-40b2-a3a0-febf486eb71b Q1 WINNING STRATEGIES WASHINGTON 50796 LAHEY HEALTH 2019 first_quarter MED Medicare reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-16T13:32:26.300000-04:00
2267378 ALEXANDER J. BECKLES, L.L.C. 9f6638fd-1db5-4d88-a968-5fe8fdf1c570 Q1 ALEXANDER J. BECKLES, L.L.C. 40038308 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2019 first_quarter MED H.R. 6505 - Medicare Negotiation and Competitive Licensing Act of 2018; Medicare Part D HOUSE OF REPRESENTATIVES 5000   0 0 2019-04-16T13:42:37.730000-04:00
2267487 BRACEWELL LLP 42c2ffa2-276a-4e4f-9d0d-0d019bcc970f Q1 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2019 first_quarter MED work related to medical gases Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of 84000   0 0 2019-04-16T14:25:01.457000-04:00
2267761 UNIVERSITY OF MIAMI 0a4c7796-8482-47f2-a58f-17254ba8dec1 Q1 UNIVERSITY OF MIAMI 39462 UNIVERSITY OF MIAMI 2019 first_quarter MED Fire Fighter Cancer Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   93000 0 0 2019-04-16T15:28:45.467000-04:00
2267802 AMERICAN SOCIETY OF ADDICTION MEDICINE cf45cc9f-f526-4f34-a3eb-9835b2ea9d09 Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2019 first_quarter MED FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs Re-introduction and modifications of the Corrections Public Health and Community Re-entry Act of 2018 - authorizes the National Institute of Corrections to make grants to, and enter cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Re-introduction and modifications of the Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Re-introduction of the Opioid Workforce Act of 2018 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Re-introduction of the Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central … Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   90000 0 0 2019-04-16T15:40:56.960000-04:00
2267855 WINNING STRATEGIES WASHINGTON 60e45483-8968-4b1d-b299-91beac208dd9 Q1 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2019 first_quarter MED Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-16T15:53:15.863000-04:00
2267874 HOLLAND & KNIGHT LLP 944f44be-2f11-4e08-87e4-185e0c9780e5 Q1 HOLLAND & KNIGHT LLP 18466 PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION 2019 first_quarter MED Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2020 Ag-FDA Appropriations bills and reports on sunscreen use in schools; Sunscreen provisions in H.R. 269, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019; issues related to state bans on sunscreen ingredients. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-04-16T15:59:23.523000-04:00
2267915 THE CORMAC GROUP, LLC 8648dd7e-1197-40cc-bb38-3bcfd9912432 Q1 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2019 first_quarter MED Appropriations, DOD, TBI research, Veterans Issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-16T16:16:38.780000-04:00
2268076 EFB ADVOCACY, LLC 730702f7-46f9-4e20-9529-693effa13b5f Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2019 first_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-16T18:19:01.643000-04:00
2268180 THE FEDERAL GROUP, INC. 5f32568e-d714-4acd-bde8-a6a7b4b260a2 Q1 THE FEDERAL GROUP, INC. 51104 ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS 2019 first_quarter MED Clinical research professional training standards Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2019-04-17T01:43:52.263000-04:00
2268290 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d621819e-5f6d-4d61-91d3-ed89e5b9313b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2019 first_quarter MED Regulation of laboratory diagnostics HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-04-17T09:52:01.320000-04:00
2268439 CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. 2c41c965-43d3-4586-b62b-f28170e79983 Q1 CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. 401103403 CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. 2019 first_quarter MED Lobbying on behalf of sick and injured 9/11 responders, survivors and their families, specifically on fully funding and extending the September 11th Victim Compensation Fund through the "Never Forget the Heroes: Permanent Authorization of the September 11th Victim Compensation Fund Act," H.R. 1327, S. 546. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2019-04-17T10:48:57.870000-04:00
2268532 MCDERMOTT WILL & SCHULTE LLP c819e03e-f936-4663-9853-48269db39182 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2019 first_quarter MED Issues impacting academic medical centers. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-04-17T11:04:23.837000-04:00
2268584 THORN RUN PARTNERS db2dc9e8-0fc0-465b-b2ad-92f0c72fe779 Q1 THORN RUN PARTNERS 400534596 CONTINUING MEDICAL EDUCATION COALITION 2019 first_quarter MED Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-04-17T11:15:47.707000-04:00
2268598 THE CORMAC GROUP, LLC 1720f4b8-8754-4530-b649-b110b1bcde4c Q1 THE CORMAC GROUP, LLC 66773 HEARTFLOW, INC. 2019 first_quarter MED Medicare payment issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-17T11:17:52.553000-04:00
2268786 THORN RUN PARTNERS 2962b1b3-4ed6-48fb-8ad9-6c8b050dfc97 Q1 THORN RUN PARTNERS 400534596 CYSTIC FIBROSIS FOUNDATION 2019 first_quarter MED Supporting National Institutes of Health (NIH) research that benefits people with cystic fibrosis. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-04-17T11:41:51.997000-04:00
2269294 AMFAR THE FOUNDATION FOR AIDS RESEARCH f509bb78-16b4-47ac-b3e8-2a4c6826e47e Q1 AMFAR THE FOUNDATION FOR AIDS RESEARCH 2398 AMFAR THE FOUNDATION FOR AIDS RESEARCH 2019 first_quarter MED Issues related to hepatitis C testing and reporting, HIV research, NIH research Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   100000 0 0 2019-04-17T13:11:53.497000-04:00
2269308 SUSAN B ANTHONY LIST e7866981-1782-4e5d-be26-c9f4a163d474 Q1 SUSAN B ANTHONY LIST 400935704 SUSAN B ANTHONY LIST 2019 first_quarter MED Bioethics - embryos, fetal tissue regulations Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),White House Office   270000 0 0 2019-04-17T13:12:56.170000-04:00
2269332 SIDLEY AUSTIN LLP b29db27b-fb58-444d-b7ee-d71c16fa532d Q1 SIDLEY AUSTIN LLP 35230 CORD BLOOD ASSOCIATION 2019 first_quarter MED Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015. Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA) 20000   0 0 2019-04-17T13:19:07.613000-04:00
2269447 ISEMAN & ASSOCIATES LLC f8112e29-9c2b-466f-9aee-736b717cd66b Q1 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2019 first_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 12500   0 0 2019-04-17T13:49:00.107000-04:00
2270008 GOVERNMENT COUNSEL, LLC 6245726a-1e85-4768-a353-76c64bd65d1d Q1 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2019 first_quarter MED The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-17T15:34:29.703000-04:00
2270103 TRAVERE THERAPEUTICS 6eb39afe-b211-459c-84c7-b195dd99c2ae Q1 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2019 first_quarter MED Medical research, NIH funding, related appropriations issues Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2019-04-17T15:52:10.077000-04:00
2270217 THORN RUN PARTNERS de802965-d49c-429e-86c1-9a42deb22dad Q1 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2019 first_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-04-17T16:09:49.013000-04:00
2270413 OREGON HEALTH & SCIENCE UNIVERSITY 167839ae-5a59-49f3-aa3c-3eb43a0a8b75 Q1 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2019 first_quarter MED Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2019-04-17T16:58:56.620000-04:00
2270557 WASHINGTON UNIVERSITY IN ST. LOUIS c8864cc0-2255-4a8c-8b45-af7a5de676d5 Q1 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2019 first_quarter MED General advocacy for NIH and other biomedical research. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2019-04-17T18:09:46.590000-04:00
2270768 SQUIRE PATTON BOGGS 08279aed-8d72-4a27-b457-3e1840b908a1 Q1 SQUIRE PATTON BOGGS 30906 THOMAS JEFFERSON UNIVERSITY 2019 first_quarter MED Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-04-18T08:05:26.873000-04:00
2270856 PARALYZED VETERANS OF AMERICA 45dc81d6-d7f8-46bc-98f0-740a8752e308 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2019 first_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues AMTRAK - Natl Railroad Passenger Corporation,HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)   77998 0 0 2019-04-18T08:51:53.787000-04:00
2270881 AMERICAN PHYSICAL THERAPY ASSOCIATION 73868323-5512-4e31-ae78-d5e35f456793 Q1 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2019 first_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   243000 0 0 2019-04-18T08:55:57.400000-04:00
2271296 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) b207cd2e-64d5-4407-abb9-0ea485a3db43 Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 COLOR HEALTH (FKA COLOR GENOMICS) 2019 first_quarter MED Lobbying related to healthcare issues. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-04-18T09:57:13.110000-04:00
2271336 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 73a96ff6-f180-46c6-a9c3-cbaab15c5868 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2019 first_quarter MED Hemophilia research, prevention, surveillance and service programs and issues Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2019-04-18T10:05:26.900000-04:00
2271460 BRACEWELL LLP aaeade7a-672a-4761-aa2a-51586463c106 Q1 BRACEWELL LLP 6837 NATIONAL BRAIN TUMOR SOCIETY 2019 first_quarter MED work related to the advancement of the Cancer Drug Coverage Parity Act and STAR Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-04-18T10:30:18.360000-04:00
2271603 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8eebcde5-3558-4358-954c-633a32b72deb Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2019 first_quarter MED Medicare/Medicaid reimbursement, clinical research HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-04-18T10:45:05.217000-04:00
2271801 AMERICAN CLINICAL LABORATORY ASSN 2e8dbd73-df3b-4ec2-8326-115e4760ffb5 Q1 AMERICAN CLINICAL LABORATORY ASSN 1923 AMERICAN CLINICAL LABORATORY ASSN 2019 first_quarter MED regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services;SUPPORT for Patients and Communities Act (PL 115-271). Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,White House Office   170793 0 0 2019-04-18T11:16:25.057000-04:00
2271993 BALLARD PARTNERS ba37b4bb-686f-4a7e-bf0d-d1efec468164 Q1 BALLARD PARTNERS 401104288 LABORATORY CORPORATIONS OF AMERICA HOLDINGS 2019 first_quarter MED Clinical Lab Rates Health & Human Services, Dept of (HHS),White House Office 80000   0 0 2019-04-18T11:37:36.183000-04:00
2272359 KANSAS STATE UNIVERSITY 66c13f8e-3f8d-450a-acfb-62bb5f77d33f Q1 KANSAS STATE UNIVERSITY 401104168 KANSAS STATE UNIVERSITY 2019 first_quarter MED cancer research and public health issues Agriculture, Dept of (USDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE   221176 0 0 2019-04-18T12:39:01.380000-04:00
2272423 THE JACKSON LABORATORY fa6be5ed-5ec0-45bc-8dda-7d5c6cd01f21 Q1 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2019 first_quarter MED Issues pertaining to basic science research and biomedical research. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)   30000 0 0 2019-04-18T12:48:22.840000-04:00
2272672 HANCE SCARBOROUGH 051fca8e-11a1-46df-801c-4e52908c2aab Q1 HANCE SCARBOROUGH 17443 TITAN PHARMACEUTICALS, INC. 2019 first_quarter MED Medicare/Medicaid drug coverage, opioid addiction policy. HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-04-18T13:21:36.653000-04:00
2273128 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 22d59b98-96c2-4183-b074-dd1515de79a4 Q1 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2019 first_quarter MED Support for Heart and Lung Research in the FY 2020 LHHS bill (no bill number). Support for Increased funding for SAMHSA and HRSA programs in the FY 2020 LHHS bill (no bill number). Support for designating a stand-alone arthritis program within the Congressionally Directed Medical Research Program (CDMRP) at the Department of Defense, funded at $20 million for FY 2020 (no bill number). Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2019-04-18T14:36:33.147000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1670.41ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API